Martingale Asset Management L P boosted its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 0.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 38,703 shares of the medical instruments supplier’s stock after buying an additional 100 shares during the period. Martingale Asset Management L P owned approximately 0.20% of ICU Medical worth $6,677,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of ICUI. BlackRock Inc. raised its holdings in ICU Medical by 87,088.7% in the 1st quarter. BlackRock Inc. now owns 1,769,930 shares of the medical instruments supplier’s stock valued at $270,268,000 after buying an additional 1,767,900 shares during the period. Janus Capital Management LLC raised its holdings in ICU Medical by 178.8% in the 1st quarter. Janus Capital Management LLC now owns 1,439,864 shares of the medical instruments supplier’s stock valued at $219,864,000 after buying an additional 923,395 shares during the period. Redmile Group LLC purchased a new stake in ICU Medical in the 1st quarter valued at about $24,515,000. Wells Fargo & Company MN raised its holdings in ICU Medical by 19.3% in the 2nd quarter. Wells Fargo & Company MN now owns 555,712 shares of the medical instruments supplier’s stock valued at $95,861,000 after buying an additional 89,872 shares during the period. Finally, Kennedy Capital Management Inc. raised its holdings in ICU Medical by 255.3% in the 1st quarter. Kennedy Capital Management Inc. now owns 120,547 shares of the medical instruments supplier’s stock valued at $18,408,000 after buying an additional 86,615 shares during the period. Hedge funds and other institutional investors own 78.13% of the company’s stock.

In other news, VP Virginia Ruth Sanzone sold 1,784 shares of the stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $174.47, for a total value of $311,254.48. Following the completion of the sale, the vice president now owns 102 shares in the company, valued at $17,795.94. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Robert S. Swinney sold 3,400 shares of the stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $175.01, for a total value of $595,034.00. Following the completion of the sale, the director now owns 15,193 shares of the company’s stock, valued at approximately $2,658,926.93. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 212,549 shares of company stock worth $36,354,740. Company insiders own 15.90% of the company’s stock.

ICUI has been the subject of several research reports. BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research report on Saturday, June 17th. Sidoti downgraded ICU Medical from a “buy” rating to a “neutral” rating in a research report on Tuesday, June 20th. Zacks Investment Research raised ICU Medical from a “hold” rating to a “strong-buy” rating and set a $195.00 target price for the company in a research report on Wednesday, July 12th. Finally, Gabelli reaffirmed a “buy” rating on shares of ICU Medical in a research report on Friday, August 11th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company’s stock. ICU Medical presently has a consensus rating of “Hold” and an average price target of $193.00.

ILLEGAL ACTIVITY WARNING: This news story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/12/icu-medical-inc-icui-shares-bought-by-martingale-asset-management-l-p.html.

ICU Medical, Inc. (ICUI) opened at 179.95 on Tuesday. The firm has a market capitalization of $3.57 billion, a P/E ratio of 72.07 and a beta of 0.36. The firm has a 50-day moving average price of $171.38 and a 200 day moving average price of $162.99. ICU Medical, Inc. has a 52-week low of $120.14 and a 52-week high of $180.15.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing analysts’ consensus estimates of $0.58 by $0.06. The firm had revenue of $331.51 million during the quarter, compared to analysts’ expectations of $318.30 million. ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The business’s revenue for the quarter was up 242.8% compared to the same quarter last year. During the same quarter last year, the business earned $1.15 earnings per share. Analysts forecast that ICU Medical, Inc. will post $4.11 EPS for the current year.

ICU Medical Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Stock Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related stocks with our FREE daily email newsletter.